SGK
TAK icon

Steigerwald Gordon & Koch’s Takeda Pharmaceutical TAK Stock Holding History

Steigerwald Gordon & Koch’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16 Hold
1
– – ﹤0.01% 762
2026
Q1 		$19 Hold
1
– – ﹤0.01% 775
2025
Q4 		$16 Hold
1
– – ﹤0.01% 911
2025
Q3 		$15 Buy
+1
New +$15 ﹤0.01% 810

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Steigerwald Gordon & Koch's TAK Position: Q2 2026 in Review

Steigerwald Gordon & Koch held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 1 share worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #762.

Steigerwald Gordon & Koch first reported a position in TAK in Q3 2025 and has held it in 4 quarters since. The position peaked at $19 in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Steigerwald Gordon & Koch held 1 share of Takeda Pharmaceutical worth $16 as of Q2 2026.
  • Steigerwald Gordon & Koch left its Takeda Pharmaceutical share count unchanged in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #762 holding.
  • Steigerwald Gordon & Koch first reported a position in Takeda Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • Steigerwald Gordon & Koch's Takeda Pharmaceutical position peaked at $19 in Q1 2026.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.